Clinical Trial Update: Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on a strategy to prevent drug-induced nephrotoxicity in high-risk patients; the study was terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Bacterial Skin and Skin Structure Infections
• Endocarditis
• Health Care Associated Pneumonia
• Osteomyelitis Septic Arthritis

Snippet

Sponsor: Henry Ford Health System | Conditions: Health Care Associated Pneumonia, Osteomyelitis/Septic Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2023-05-03